|
[1]
|
Frank, R.N. (2004) Diabetic Retinopathy. The New England Journal of Medicine, 1, 48-58. [Google Scholar] [CrossRef]
|
|
[2]
|
Ponnalagu, M., Subramani, M., Jayadev, C., Shetty, R. and Das, D. (2017) Retinal Pigment Epithelium-Secretome: A Diabetic Retinopathy Perspective. Cytokine, 95, 126-135. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Esser, P., Heimann, K., Bartz-schmidt, K.U., et al. (1997) Apopto-sis in Proliferative Vitreoretinal Disorders: Possible Involvement of TGF-Beta-Induced RPE Cell Apoptosis. Experi-mental Eye Research, 3, 365-378. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Tu, W., Wang, H., Li, S., Liu, Q. and Sha, H. (2019) The An-ti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases. Aging and Disease, 3, 637-651. [Google Scholar] [CrossRef]
|
|
[5]
|
Tan, S.W., Xie, T., Malik, T.H. and Gao, Y. (2022) Advances of Neurovascular Protective Potential of 3-N-Butylph- thalide and Its Derivatives in Diabetic Related Diseases. Journal of Diabetes and Its Complications, 11, Article ID: 108335. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
(2021) Causes of Blindness and Vision Impairment in 2020 and Trends over 30 Years, and Prevalence of Avoidable Blindness in Relation to VISION 2020: The Right to Sight: An Analysis for the Global Burden of Disease Study. The Lancet Global Health, 2, e144-e160.
|
|
[7]
|
Fong, D.S., Aiello, L.P., Ferris, F.L. and Klein, R. (2004) Diabetic Retinopathy. Diabetes Care, 10, 2540-2553. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Bursell, S.E., Clermont, A.C., Aiello, L.P., et al. (1999) High-Dose Vitamin E Supplementation Normalizes Retinal Blood Flow and Creatinine Clearance in Patients with Type 1 Diabetes. Diabetes Care, 8, 1245-1251. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Xing, X., Huang, L., Lv, Y., et al. (2019) DL-3-n-Butylphthalide Protected Retinal Müller Cells Dysfunction from Oxidative Stress. Current Eye Research, 10, 1112-1120. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Wang, F., Ma, J., Han, F., et al. (2016) DL-3-n-butylphthalide Delays the Onset and Progression of Diabetic Cataract by Inhibiting Oxidative Stress in Rat Dia-betic Model. Scientific Reports, 6, Article No. 19396. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kenarova, B., Voinov, L., Apostolov, C., Vladimirova, R. and Misheva, A. (1997) Levels of Some Cytokines in Subretinal Fluid in Proliferative Vitreoretinopathy and Rhegmatogenous Retinal De-tachment. European Journal of Ophthalmology, 1, 64-67. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Dhakshinamoorthy, S., Long, D.J. and Jaiswal, A.K. (2000) Antioxidant Regulation of Genes Encoding Enzymes That Detoxify Xenobiotics and Carcinogens. Current Topics in Cellular Regulation, 36, 201-216. [Google Scholar] [CrossRef]
|
|
[13]
|
Chen, J., Xiao, L., Chen, Y., et al. (2022) Butylphthalide Al-leviates Sleep Deprivation-Induced Cognitive Deficit by Regulating Nrf2/HO-1 Pathway. Sleep Medicine, 100, 427-433. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Sun, M., Jiang, C., Hao, X., et al. (2022) Long-Term L-3-n-butylphthalide Pretreatment Attenuates Ischemic Brain Injury in Mice with Permanent Distal Middle Cerebral Ar-tery Occlusion through the Nrf2 Pathway. Heliyon, 7, e09909. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Zhang, X., Wu, Q., Wang, Z., Li, H. and Dai, J. (2022) Keap1-Nrf2/ARE Signal Pathway Activated by Butylphthalide in the Treatment of Ischemic Stroke. American Journal of Translational Research, 4, 2637-2646.
|